Home
Yu-Waye Chu, Chief Medical Officer: Fate Therapeutics FATE Sell · Filed 23/04/19
Trade details
- Type
- Insider sale
- Amount
- $15,245.86
- Shares · price
- 2,317 sh · $6.58 a share
- Held after
- 140,676 sh
- Trade date
- 23/04/18
- Filed
- 23/04/19
- Days to filing
- 1 days
Sold 1.6% of holdings
- Share of holding sold
- 1.6%
Fate Therapeutics trades, last 26 weeks
What else happened in Fate Therapeutics around then
Filed or reported within 30 days of the trade day · 23/03/19~23/05/18Yu-Waye Chu's recent trades
- Yu-Waye Chu
SellCytomX Therapeutics
SellCytomX Therapeutics
CTMX
$136.6K
21,279 sh
$136.6K
Filed 03/19
Traded 03/17
- Yu-Waye Chu
SellCytomX Therapeutics
SellCytomX Therapeutics
CTMX
$2,415
4,025 sh
$2,415
Filed 25/03/20
Traded 25/03/18
- Yu-Waye Chu
Sell10b5-1 planFate Therapeutics
Sell10b5-1 planFate Therapeutics
FATE
$1,402
215 sh
$1,402
Filed 23/04/19
Traded 23/04/18
- Yu-Waye Chu
SellFate Therapeutics
SellFate Therapeutics
FATE
$41K
7,825 sh
$41K
Filed 23/01/11
Traded 23/01/10
